| Literature DB >> 27356470 |
Kundan Kumar Chaubey1,2, Rinkoo Devi Gupta3, Saurabh Gupta1,2, Shoor Vir Singh1, Ashok Kumar Bhatia2, Sujata Jayaraman4, Naveen Kumar1, Anjana Goel2, Abhishek Singh Rathore3, Jagdip Singh Sohal4, Bjorn John Stephen1, Manju Singh1, Manish Goyal5, Kuldeep Dhama6, Abdollah Derakhshandeh7.
Abstract
Paratuberculosis (pTB) is a chronic granulomatous enteritis caused by Mycobacterium avium subsp. paratuberculosis (MAP) in a wide variety of domestic and wild animals. Control of pTB is difficult due to the lack of sensitive, efficacious and cost-effective diagnostics and marker vaccines. Microscopy, culture, and PCR have been used for the screening of MAP infection in animals for quite a long time. Besides, giving variable sensitivity and specificity, these tests have not been considered ideal for large-scale screening of domestic livestock. Serological tests like ELISA easily detects anti-MAP antibodies. However, it cannot differentiate between the vaccinated and infected animals. Nanotechnology-based diagnostic tests are underway to improve the sensitivity and specificity. Newer generation diagnostic tests based on recombinant MAP secretory proteins would open new paradigm for the differentiation between infected and vaccinated animals and for early detection of the infection. Due to higher seroreactivity of secretory proteins vis-à-vis cellular proteins, the secretory proteins may be used as marker vaccine, which may aid in the control of pTB infection in animals. Secretory proteins can be potentially used to develop future diagnostics, surveillance and monitoring of the disease progression in animals and the marker vaccine for the control and eradication of pTB.Entities:
Keywords: Cattle; Johne's disease; Mycobacterium avium subsp. paratuberculosis; paratuberculosis; review; secretory proteins
Mesh:
Substances:
Year: 2016 PMID: 27356470 DOI: 10.1080/01652176.2016.1196508
Source DB: PubMed Journal: Vet Q ISSN: 0165-2176 Impact factor: 3.320